U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035691) titled 'New bioMarkers tO straTIfy cOlorectal caNcer Referrals' on June 11.
Brief Summary: The goal of this observational study is to evaluate if a blood test for circulating progastrin (hPG80) and transposable elements (TEs) can accurately predict colorectal cancer (CRC) or polyps in adult patients referred to the 2-week wait (2WW) or Straight to Test (STT) pathways for suspected lower gastrointestinal cancer.
The main questions it aims to answer are:
Can plasma hPG80 levels accurately predict a diagnosis of CRC or polyps in patients undergoing standard 2WW investigations? Can transposable elements (TEs) in the plasma serve as predictive...